|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 09-29-2004
NEW YORK (Reuters Health) - Two drugs commonly prescribed for schizophrenia - clozapine and olanzapine -- may carry a small risk of an increased risk of diabetes, new research shows.
NEW YORK (Reuters Health) - Fish oil may help lower the risk of breast cancer, but the benefit may depend largely on a woman's genetic makeup, researchers have found.
BANGKOK (Reuters) - Thailand's prime minister ordered a campaign to wipe out the bird flu virus by the end of October on Wednesday, a day after the country announced its first probable case of human transmission.
WASHINGTON (Reuters) - The U.S. government on Tuesday proposed expanding Medicare coverage for costly, potentially life-saving implanted heart devices, a decision expected to benefit makers Guidant Corp., Medtronic Inc. and St. Jude Medical Inc.
WASHINGTON (Reuters) - Three dozen eminent pediatricians and social workers attacked the Bush administration on Wednesday for policies they said leave too many children without health insurance.
WASHINGTON (Reuters) - Americans are caught between worries over the safety of the flu vaccine and fears that they will not be able to get it when they need it, a health official told Congress on Tuesday.
WASHINGTON (Reuters) - Drug makers will not need regulatory approval for every change in their manufacturing processes under new guidelines designed to prevent supply disruptions, U.S. health officials said on Wednesday.
HANOI (Reuters) - The World Health Organization (WHO) expects the world's first treaty on tobacco control will take effect by early 2005, the international body said on Wednesday.
NEW YORK (Reuters) - A drug being developed by Bayer AG and Onyx Pharmaceuticals shrank tumors in 9 percent of liver cancer patients in a mid-stage clinical trial, the companies said on Wednesday.
BEIJING (Reuters) - Pfizer Inc., the world's biggest drugmaker, has appealed to a Beijing court against a decision to overturn its China patent for its erectile dysfunction drug Viagra, a newspaper said on Wednesday.
|
|
